概括
来自子的某些腺病毒可以在子中引起瘤. 来自Cercopithecus子的一种特定的腺病毒表现出高瘤性,在接种过疫苗的子中迅速诱导淋巴瘤.
科学领域:
- 病毒学 病毒学
- 在瘤学瘤学.
- 灵长类腺病毒是灵长类腺病毒
背景情况:
- 腺病毒是常见的病毒,具有多样化的宿主.
- 已知一些腺病毒会在实验动物中引起瘤.
- 来自非人类灵长类动物的腺病毒的致癌潜力需要进一步调查.
研究的目的:
- 研究从 rhesus, cynomolgus 和 Cercopithecus 子中分离出来的腺病毒的致癌潜力.
- 为了描述这些腺病毒诱导的瘤在新生哈姆斯特.
主要方法:
- 新生哈姆斯特犬的皮下注射17种不同的来自子的腺病毒.
- 瘤监测,特征 (组织病理学,交叉补充固定试验).
主要成果:
- 在17种腺病毒中,有5种诱导瘤,主要是淋巴瘤,在注射42至280天后的仓鼠中.
- 通过交叉补充固定试验证实了瘤特异性.
- 一种来自Cercopithecus子的腺病毒具有高度致癌性,在30-40天内导致所有23只接种疫苗的子的瘤.
结论:
- 来自 rhesus 和 cynomolgus 子的腺病毒在子中具有致癌潜力.
- 来自Cercopithecus子的一种特定的腺病毒表现出显著的致癌性,迅速诱导淋巴瘤.
- 这些发现凸显了研究灵长类腺病毒及其致癌能力的重要性.
更多相关视频
13:36Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
06:25Analysis of Simian Immunodeficiency Virus-specific CD8+ T-cells in Rhesus Macaques by Peptide-MHC-I Tetramer Staining
Published on: December 23, 2016
相关概念视频
Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
